75 filings
8-K
AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares
7 May 24
Submission of Matters to a Vote of Security Holders
4:18pm
8-K
AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares
3 May 24
Amneal Reports First Quarter 2024 Financial Results
6:14am
8-K
AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares
1 Mar 24
Amneal Reports Fourth Quarter and Full Year 2023 Financial Results
6:13am
8-K
AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares
10 Jan 24
Results of Operations and Financial Condition
7:03am
8-K
AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares
15 Dec 23
Amneal Announces Move to Nasdaq
4:15pm
8-K/A
zfjwohit5g
15 Dec 23
Financial Statements and Exhibits
4:06pm
8-K
r0vs19h4zw4q
14 Nov 23
Entry into a Material Definitive Agreement
5:04pm
8-K
gvnhmbqq23 ele8
7 Nov 23
Amneal Reports Third Quarter 2023 Financial Results
6:21am
8-K
u63eklyb
23 Oct 23
Amneal Reports Certain Preliminary Third Quarter 2023 Financial Results
4:16pm
8-K
ysbeumt0rv093syr4w
17 Oct 23
Entry into a Material Definitive Agreement
6:51am
8-K
k2cm389pg5rotk9
4 Aug 23
Amneal Reports Second Quarter 2023 Financial Results
6:22am
8-K
bqlnaqceht
19 May 23
In the Court of Chancery of the State of Delaware
4:06pm
8-K
w396apwk4r
12 May 23
Submission of Matters to a Vote of Security Holders
4:29pm
8-K
p25fysrvfcj1
5 May 23
Amneal Reports First Quarter 2023 Financial Results
6:17am
8-K
tpb9f4d9qm6k580em
17 Apr 23
Amneal Reports Certain Preliminary First Quarter 2023 Financial Results
6:43am
8-K
frk7r66 cybr185m6
2 Mar 23
Amneal Reports Fourth Quarter and Full Year 2022 Financial Results
6:27am
8-K
rq1i4pd4mj1jro
10 Jan 23
Results of Operations and Financial Condition
6:05am
8-K
ygl35zovwko
4 Nov 22
Amneal Reports Third Quarter 2022 Financial Results
6:24am
8-K
b291e
6 Sep 22
Amneal Appoints Gustavo Pesquin as Executive Vice President, Chief Commercial Officer – Specialty
4:15pm
8-K
yuubz0ixfi6v4
5 Aug 22
Amneal Reports Second Quarter 2022 Financial Results
6:11am